ACE Report Cover
A network meta-analysis of osteoporotic vertebral compression fracture treatments
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Sprache
Download Download Download
Herunterladen
Cite this Report Cite this Report Cite this Report
Zitieren
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoriten
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Sprache
Download Download Download
Herunterladen
Cite this Report Cite this Report Cite this Report
Zitieren
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoriten
SPINE
A network meta-analysis of osteoporotic vertebral compression fracture treatments .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2016;4(14):33 PLoS One. 2015 Apr 13;10(4):e0123153

Five randomized controlled trials (RCT) with a total of 777 patients were included in this meta-analysis to analyze the efficacy of percutaneous vertebroplasty (PVP), balloon kyphoplasty (BK), and conservative treatment (CT) in elderly patients with an osteoporotic vertebral compression fracture. Visual analogue scale (VAS), the risk of all-cause discontinuation, and the incidence of new fractures were used to assess and compare the three treatments options. Pooled results demonstrated PVP to be more beneficial for pain relief, and BK correlated with lower risk of all-cause discontinuation, although additional, larger-scale studies longer duration follow-ups are needed for a more conclusive analysis.


Details zur Finanzierung der Veröffentlichung +
Finanzierung:
Non-Industry funded
Sponsor:
Applied Basic Research Programs of Science and Technology Commission of Tianjin, National Natural Science Funds of China, National Natural Science Funds of China, NSFC-RFBR and Sino-australian cooperation projects
Conflicts:
None disclosed

Risiko der Voreingenommenheit

9,5/10

Kriterien für die Berichterstattung

19/20

Fragilitäts-Index

N/A

Were the search methods used to find evidence (original research) on the primary question or questions stated?

Was the search for evidence reasonably comprehensive?

Were the criteria used for deciding which studies to include in the overview reported?

Was the bias in the selection of studies avoided?

Were the criteria used for assessing the validity of the included studies reported?

Was the validity of all of the studies referred to in the text assessed with use of appropriate criteria (either in selecting the studies for inclusion or in analyzing the studies that were cited)?

Were the methods used to combine the findings of the relevant studies (to reach a conclusion) reported?

Were the findings of the relevant studies combined appropriately relative to the primary question that the overview addresses?

Were the conclusions made by the author or authors supported by the data and or analysis reported in the overview?

How would you rate the scientific quality of this evidence?

Ja = 1

Ungewiss = 0.5

Nicht relevant = 0

Nein = 0

Die Bewertung der Berichtskriterien bewertet die Transparenz, mit der die Autoren die methodischen und studienspezifischen Merkmale der Studie in der Veröffentlichung angeben. Die Bewertung ist in fünf Kategorien unterteilt, die im Folgenden vorgestellt werden.

4/4

Introduction

4/4

Accessing Data

4/4

Analysing Data

4/4

Results

3/4

Discussion

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

Der Fragilitätsindex ist ein Instrument, das bei der Interpretation signifikanter Ergebnisse hilft und ein Maß für die Stärke eines Ergebnisses liefert. Der Fragilitätsindex gibt die Anzahl der aufeinanderfolgenden Ereignisse an, die zu einem dichotomen Ergebnis hinzugefügt werden müssen, damit das Ergebnis nicht mehr signifikant ist. Eine kleine Zahl steht für ein schwächeres Ergebnis und eine große Zahl für ein stärkeres Ergebnis.

Warum wurde diese Studie jetzt benötigt?

Patients with osteoporosis, mainly the elderly, often suffer vertebral compression fractures. Common treatments for these fractures are percutaneous vertebroplasty (PVP), balloon kyphoplasty (BK), and conservative treatment (CT). Previous meta-analyses have been limited in the number comparisons that can be made between the three treatments and the number of trials included. As a result, there is an ongoing discussion surrounding comparative efficacy of these treatments. This network meta-analysis was synthesized to provide a hierarchy of the three treatments based on pain, the risk of all-cause discontinuation, and the incidence of new fractures.

Was war die wichtigste Forschungsfrage?

Which of the three treatments: percutaneous vertebroplasty (PVP), balloon kyphoplasty (BK), and conservative treatment (CT), is the most effective and tolerable treatment in elderly patients with osteoporotic vertebral compression fractures?

Merkmale der Studie +
Data Source:
Amed (1985 - July 2014), British Nursing Index (1985 - July 2014), Embase (1974 - July 2014), Pubmed (1966 - July 2014),Cochrane Central Register of Controlled Trials, Google scholar, System for Information on Grey Literature in Europe (SIGLE), the National Technical Information Service, the National Research Register (UK), and the Current Controlled Trials databases were searched for relevant studies. Reference lists were also reviewed for ignored articles.
Index Terms:
The terms "balloon kyphoplasty", "vertebroplasty", "conservative treatment", "optimum pain treatment", "optimal medical therapy", "osteoprotic", and "vertebral compression fracture" were searched.
Study Selection:
Inclusion criteria were randomized controlled trials evaluating patients with osteoporotic vertebral compression fractures who were older than 60 years of age. The trials evaluated 2 of BK, PVP, and CT and assessed outcomes for pain, the risk of all-cause discontinuation, and the incidence of new fractures. Two researchers independently selected the studies and disagreements were resolved by discussion. Debates that were unable to be resolved through discussion were consulted with a further researcher and expert. Five RCTs containing a total of 777 elderly patients with osteoporotic vertebral compression fractures were included in this study.
Data Extraction:
One review author extracted data from the included studies. The original author would be contacted for clarification on studies with missing information. The extracted data was entered into Excel by two reviewers and reviewed amongst each other. Discrepancies were resolved by going back to the original publications.
Data Synthesis:
Stata (version 12.0) software was used to compile the five RCTs in this study. Standardized mean differences (SMDs), with 95% confidence intervals (CIs) for direct comparisons and 95% credible intervals (CrI), were calculated for continuous outcomes. Dichotomous data was calculated for risk of all-cause discontinuation and incidence of new fractures. Chi-square and I-square tests were used to determine heterogeneity. Surface under the cumulative ranking probabilities (SUCRA) was used to determine the hierarchy of the three treatments.
Was waren die wichtigsten Ergebnisse?
  • A total of 5 randomized clinical trials were included in the network meta-analysis.
  • Direct and indirect comparisons on visual analogue scale (VAS) scores indicated greater reduction in pain with PVP (3/5 studies; p>0.0001, p=0.028, p>0.0001) and BK (1/5 studies; p<0.0001) treatments compared to CT; according to SUCRA, PVP ranked first, BK second, and CT placed third
  • Direct comparisons evaluating the risk of all-cause discontinuation were significantly lower in BK (1/5 studies; p=0.036) compared to CT; according to SUCRA, BK ranked first, PVP second, and CT was third
  • Studies assessing the incidence of new fractures (36/5 studies) demonstrated no significant differences between treatments (p=0.22, 0.769, 0.065); according to SUCRA, CT had the lowest probability of new fractures, BK in second place, and PVP ranked third
  • One study demonstrated PVP to be the suggested treatment when measured by cost-effectiveness
Was sollte ich mir besonders merken?

Pooled results demonstrated that PVP may be more beneficial for pain relief, and BK may demonstrate a lower risk of all-cause discontinuation in elderly osteoporotic vertebral compression fracture patients. However, definitive conclusions cannot be made based on these findings as this study was limited by the number of available trials and the number of patients included; further studies are needed to strengthen the body of evidence from which clinical decisions can be made with regards to the management of compression fractures in the elderly.

Wie wird sich dies auf die Behandlung meiner Patienten auswirken?

Few clinical recommendations can be made based on the results of this research. While PVP treatment showed greater beneficial outcomes for pain relief, and BK was shown to have the lowest risk of all-cause discontinuation in elderly patients with an osteoporotic vertebral compression fracture, the overall body of evidence was limited quantity and quality. Future studies with larger and more uniform patient population are needed to combat heterogeneity and longer follow-up durations in studies are needed to examine the effects of these three management options.

HAFTUNGSAUSSCHLUSS

Der Inhalt dieser Seite dient nur zu Informationszwecken und ist nicht als Ersatz für professionelle medizinische Beratung, Diagnose oder Behandlung gedacht. Wenn Sie eine medizinische Behandlung benötigen, wenden Sie sich immer an Ihren Arzt oder suchen Sie die nächstgelegene Notaufnahme auf. Die Meinungen, Überzeugungen und Standpunkte, die von den Personen auf dieser Seite geäußert werden, spiegeln nicht die Meinungen, Überzeugungen und Standpunkte von OrthoEvidence wider.

0 von 4 monatliche KOSTENLOSE Artikel freigeschaltet
Sie haben Ihr Limit von 4 kostenlosen Artikeln in diesem Monat erreicht

Zugang zu OrthoEvidence für nur $1,99 pro Woche.

Bleiben Sie auf dem Laufenden mit den neuesten Beweisen. Jederzeit kündbar.
  • Kritische Beurteilungen der neuesten, hochwirksamen randomisierten kontrollierten Studien und systematischen Übersichten in der Orthopädie
  • Zugang zu OrthoEvidence-Podcast-Inhalten, einschließlich Kooperationen mit dem Journal of Bone and Joint Surgery, Interviews mit international anerkannten Chirurgen und Diskussionsrunden zu orthopädischen Neuigkeiten und Themen
  • Abonnement von The Pulse, einem zweimal wöchentlich erscheinenden evidenzbasierten Newsletter, der Ihnen helfen soll, bessere klinische Entscheidungen zu treffen
Upgrade
Willkommen zurück!
Passwort vergessen?
Starten Sie Ihre KOSTENLOSE Testversion noch heute!

Ihr Konto ist verbunden mit
und umfasst den kostenlosen Zugang zu OrthoEvidence


ODER
Passwort vergessen?

ODER
Bitte überprüfen Sie Ihre E-Mail

Wenn ein Konto mit der angegebenen E-Mail-Adresse existiert, wird Ihnen eine E-Mail zum Zurücksetzen des Passworts zugesandt. Wenn Sie keine E-Mail sehen, überprüfen Sie bitte Ihren Spam- oder Junk-Ordner.

Für weitere Hilfe, kontaktieren Sie unser Support-Team.

Bitte melden Sie sich an, um diese Funktion zu aktivieren

Um auf diese Funktion zugreifen zu können, müssen Sie bei einem aktiven OrthoEvidence-Konto angemeldet sein. Bitte melden Sie sich an oder erstellen Sie ein KOSTENLOSES Testkonto.

Übersetzen ACE Report

OrthoEvidence nutzt einen externen Übersetzungsdienst, um Inhalte in mehreren Sprachen zugänglich zu machen. Bitte beachten Sie, dass trotz aller Bemühungen um Genauigkeit die Übersetzungen nicht immer perfekt sind.

Wie man dies zitiert ACE Report

OrthoEvidence. A network meta-analysis of osteoporotic vertebral compression fracture treatments. OE Journal. 2016;4(14):33. Available from: https://myorthoevidence.com/AceReport/Show/a-network-meta-analysis-of-osteoporotic-vertebral-compression-fracture-treatments

Zitat kopieren
Bitte melden Sie sich an, um diese Funktion zu aktivieren

Um auf diese Funktion zugreifen zu können, müssen Sie bei einem aktiven OrthoEvidence-Konto angemeldet sein. Bitte melden Sie sich an oder erstellen Sie ein KOSTENLOSES Testkonto.

Premium-Mitglied-Funktion

Um auf diese Funktion zugreifen zu können, müssen Sie bei einem Premium-Konto von OrthoEvidence angemeldet sein.

Teilen Sie dies ACE Report